Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 12.0655 | 99 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 11.7628 | 99 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 12.4379 | 99 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 11.727 | 99 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 12.2916 | 99 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 11.0133 | 99 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 11.5103 | 99 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 11.7726 | 99 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 11.6312 | 99 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 11.6405 | 99 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 11.1324 | 99 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 11.3022 | 99 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 11.8765 | 99 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 10.9048 | 99 |